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Abstract
Background: Molecular measurements from cancer patients such as gene expression and DNA methylation can be
influenced by several external factors. This makes it harder to reproduce the exact values of measurements coming
from different laboratories. Furthermore, some cancer types are very heterogeneous, meaning that there might be
different underlying causes for the same type of cancer among different individuals. If a model does not take potential
biases in the data into account, this can lead to problems when trying to predict the stage of a certain cancer type.
This is especially true when these biases differ between the training and test set.
Results: We introduce a method that can estimate this bias on a per-feature level and incorporate calculated feature
confidences into a weighted combination of classifiers with disjoint feature sets. In this way, the method provides a
prediction that is adjusted for the potential biases on a per-patient basis, providing a personalized prediction for each
test patient. The new method achieves state-of-the-art performance on many different cancer data sets with
measured DNA methylation or gene expression. Moreover, we show how to visualize the learned classifiers to display
interesting associations with the target label. Applied to a leukemia data set, our method finds several ribosomal
proteins associated with the risk group, which might be interesting targets for follow-up studies. This discovery
supports the hypothesis that the ribosomes are a new frontier in genadaptivelearninge regulation.
Conclusion: We introduce a new method for robust prediction of phenotypes from molecular measurements such
as DNA methylation or gene expression. Furthermore, the visualization capabilities enable exploratory analysis on the
learnt dependencies and pave the way for a personalized prediction of phenotypes. The software is available under
GPL2+ from https://github.com/adrinjalali/Network-Classifier/tree/v1.0.
Keywords: Machine learning, Cancer biomarkers, Supervised prediction, Ensemble methods, Support vector
machines, Gaussian processes
Background
Over the past few decades, biology has transformed into
a high throughput research field, both in terms of the
number of different measurement techniques as well as
the amount of variables measured by each technique (e.g.,
from Sanger sequencing to deep sequencing), and is more
and more targeted to individual cells [1]. This has led
to an unprecedented growth of biological information.
Consequently, techniques that can help researchers find
important insights into the data are becoming increasingly
important. Predicting survival of cancer patients based on
measurements from microarray experiments has been a
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field of great interest, but there is often very little over-
lap between the important genes or biomarkers identified
by different studies [2]. Several reasons have been sug-
gested to explain these findings (e.g., heterogeneity of
cancer samples or insufficient sample size). Attempts have
been made to incorporate additional information from
other sources, such as protein-protein interaction (PPI)
networks, to make the predictions more robust [3]. One
of the latest approaches integrates network and expres-
sion data by introducing a network-induced classification
kernel (NICK) [4]. Although this method exhibits state-
of-the-art performance, the way it penalizes genes that are
connected to not-predictive genes can result in selection
of isolated features as important features for prediction.
We observed this bias of the method towards isolated
© 2016 Jalali and Pfeifer. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
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nodes on additional experiments on synthesized data as
shown in Additional file 1. Another issue is that in PPI
networks, genes or proteins, which have been known
to researchers longer and are well-known, are studied
more and therefore have more edges connected to them;
whereas less well-known genes and proteins are in sparser
areas of the network. This bias might further affect the
judgment of methods like NICK that use a PPI networks
as an input. Consequently, we rely on the fact that such
networks exist between genes and proteins, but we do
not take them as input. If there is a dependence between
input features, which is the case in many biological set-
tings, our method can benefit from this effect. Otherwise,
it is reduced to a standard ensemble method. Further-
more, a central assumption underlying many methods is
that all data are drawn from the same unknown underly-
ing distribution. This may not be the case, especially for
heterogeneous cancer samples, and in particular not for
all measured genes.
In this work, we introduce a method that is aware of this
potential bias and utilizes an estimate of the differences
during the generation of the final prediction method. For
this, we introduce a set of sparse classifiers based on
L1-SVMs [5], where each set of features used by one clas-
sifier is disjoint from the selected feature set of any other
classifier. Furthermore, for each feature chosen by one
of the classifiers, we introduce a regression model that
uses additional features and is based on Gaussian pro-
cess regression. These regression models are then used
to estimate how predictable the features of each classi-
fier are for each test sample. This information can then be
used to find a confidence weighting of the classifiers, i.e.
up-weighting classifiers with high confidence and down-
weighting classifiers with lower confidence, for each test
sample. Schapire and Singer show that incorporating con-
fidences of classifiers can improve the performance of an
ensemble method [6]. However, in their setting, confi-
dences of classifiers are estimated using the training data
and are thus fixed for all test samples, whereas in our set-
ting, we estimate confidences of individual classifiers per
given test sample. Another related work includes mixture
of experts, in which the model trains a set of neural net-
works and uses a gating network to set the weights of the
networks [7]. One issue with their method is that neural
networks with lower performance will not be optimized
as much as networks with better performance on train-
ing data since the gate module down-weights the error
propagated to them. Also training of the gating network
is interconnected with the neural network experts and
afftects training of those modules. Our method, in con-
trast, trains each module independently using all training
samples, and their reliability does not affect how they are
trained. Bayesian hierarchical mixtures of experts takes a
more similar approach, but the method is complex, and it
has a high time complexity to train the architecture of the
hierarchy [8].
We show that this method exhibits state-of-the-art per-
formance for different cancer types, with gene expression
or methylation data sets as the input. Since the weighting
of the classifiers is customized for each test sample, the
estimated confidences can offer insights into the specific
characteristics of each individual’s cancer. To facilitate
interpretation of the model, we then create a visualiza-
tion of the important genes found through this analysis for
each test sample. Additionally, we show how the impor-
tant genes of the training set can be found using our
learning method and cross validation.
Our idea might resemble ensemble feature selection,
which involves aggregating multiple feature scores from
several scoring mechanisms. These scoring mechanisms
vary from being several different methods, to being the
same method applied to different parts of the data such as
a random cross validation scheme [9]. This idea has been
studied further by other researchers and they introduced
two different methods to aggregate scores from different
models. They use an ensemble of support vectormachines
which on its own has been used to select features in a
given data set in other works [10]. Although we use an
ensemble of support vector machines, our goal is not to
give a ranking to features of the data set, rather to find
multiple parsimonious gene sets that are predictive of the
outcome on their own, and use all of them in parallel to
predict the outcome.
Similar to this approach, in another work, iRDA uses
a different approach and can report multiple parsimo-
nious gene sets [11]. One significant difference between
iRDA and our work is that we have an embedded pre-
diction approach using these sets, which iRDA lacks.
Furthermore, gene sets are somehow ordered in iRDA
according to their “strength”, and within each set, redun-
dant genes are removed. In our model redundant genes
can be included in two different ways. One is within dif-
ferent individual learners. For example, if genes g1 and g2
are both strong but redundant, individual learner 1 might
include g1, and individual learner 2 might include g2. Also,
if there are more redundant or related genes in the gene
pool, they will be used to estimate how reliable g1 and g2
are. Therefore instead of dismissing them, we exploit the
fact that they exist.
Related to sorting genes and testing for significance of a
reported gene set, Gene Set Enrichment Analysis (GSEA)
and its modifications are a commonly used tool [12, 13].
GSEA basedmethods rank genes depending on howmuch
they relate to the outcome. The choice of relationship
is rather free and can vary from Pearson correlation to
mutual information. Then for a given gene set, a p-value
is calculated by estimating how often a random gene set
appears before the given set on the list. There have been
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several modifications and improvements to the method
[14, 15]. Although it is true that GSEA is used to assess the
relevance or importance of a given set to the outcome, we
need to remember that a particular gene set might consist
of genes that are not necessarily important on their own,
but are predictive once considered together. Our method
does not consider genes individually whereas GSEA does
to sort the genes in the first place. Therefore we believe





In this article, our method is applied to two different
data types: gene expression data and DNA methylation
data, which we retrieved from The Cancer Genome Atlas
(TCGA) [16]. TCGA is a joint effort of the National Can-
cer Institute and the National Human Genome Research
Institute to advance the understanding of the molecular
basis of cancer. They provide access to the different mea-
surements from cancer samples that have been analyzed
to external researchers. Samples are categorized accord-
ing to diagnosed cancer from which we use the following
groups:
• Acute Myeloid Leukemia (LAML) [17]: At the time
of writing, the data set includes 200 samples. 194
samples contain methylation data and we use the part
of the data measured by JHU-USC
HumanMethylation450 arrays. 173 samples contain
mRNA data measured by HG-U133 arrays. In this
article the methylation data is referred to as
TCGA-LAML. Among available characteristics of
samples, “risk group” and “vital status” are chosen as
target classes. These labels show the aggressiveness of
the disease. In our analysis, regarding risk group,
{favorable} and {intermediate/normal, poor} samples
form our two group, and in the analysis of vital status,
{alive} and {dead} samples form our two groups of
samples.
• Breast invasive carcinoma (BRCA) [18]: This data set
includes 993 samples with clinical data, and we use
the methylation data component measured by
JHU-USC HumanMethylation450 arrays. Only very
few samples in this data set are indicated as having
metastasized (8 samples). Hence the data are analyzed
according to “tumor size”, “affected nearby lymph
nodes”, “stage”, and “estrogen receptor”. Estrogen
receptor was shown to be an important factor in
prognosis [19], and along with other factors directly
affects the decision for therapy [20, 21]. For tumor
size {T1, T2} samples are one category and {T3, T4}
the other category; in order to analyze affected nearby
lymph nodes, {N0} is compared to {N1, N2, N3}; stage
is analyzed as having {stage I, stage II} vs. {stage III}
samples. Estrogen receptor status of samples is either
positive or negative, and they form our two classes.
Data preprocessing
To prepare gene expression data for analysis, microar-
ray probes are mapped to their respective gene. If there
are multiple probes for a gene, the median reported gene
expression value of those probes is adopted as the gene
expression for that gene.
Preparing the methylation data, we use the nearby gene
for each methylation site available for each sample and
each methylation site. The median beta value of methyla-
tion sites mapped to each gene is taken as the methylation
value of the corresponding gene. In this process only
methylation sites located on the promoter region of a gene
are considered and others are discarded.
Boosting
For a given prediction problem the idea of boosting is
to find an optimal combination of classifiers, also called
“weak learners” [22]. There are many methods of finding
the optimal combination of such weak learners, two of
which are stochastic gradient boosting [23] and AdaBoost
[24]. Stochastic gradient boosting tries to estimate the
gradients of the loss function and train each individual
weak learner in a way that best improves the loss func-
tion. AdaBoost tries to identify samples among given data
samples that are harder to classify, and gives them more
weight in the process of training individual weak learners.
One way of improving AdaBoost is to take into account
the confidences of predictions given by weak learners
if possible and use estimated confidences in the voting
process [6].
Learning a mixture of disjoint classifiers
When dealing with cancer, we need to consider the fact
that tumors of the same type of cancer can be very dif-
ferent in nature and they are usually classified as different
cancer subtypes. In fact, even one single tumor can be
very heterogeneous [25]. This means that the malignan-
cies causing the cancer to happen are genetically different
between subtypes, or even within subtypes, and it is possi-
ble to have multiple underlying cellular processes causing
a particular cancer. Also it is important to note that the
nature of our given data is such that the input features
are properties measured from genes, e.g. gene expression
or methylation values, and these variables are correlated
and statistically dependent on each other. Our method
tries to exploit these properties of the problem to infer an
interpretable model with state-of-the-art performance.
Our method can be characterized by the following key
parts:
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Training phase:
• Fit several individual classifiers to the data, in such a
way that the features of the data they use are disjoint
sets.
Prediction phase:
• Calculate the prediction confidence of each
individual classifier by:
– Estimating the reliability of input features of
the classifier;
– Estimating the confidence of the output based
on the decision values.
• Calculate a weighted prediction label based on the
individual classifier confidences.
Properties of the individual classifiers
A wide variety of classifiers is possible within our frame-
work. One requirement is that the classifier is regularized
(i.e., the stronger the regularization, the less complex the
model gets and consequently the less features are used).
The classifier is also required to report the probability of
its calculated output, or to give a decision value accord-
ing to which it chooses the predicted class. We use an L1
regularized SVM for this purpose with a linear kernel [5].
The L1 regularization makes the SVM sparse, i.e. using
only a few input features, and the linear kernel allows us
to infer which features are used in the decision function of
the SVM after it is fit to the data.
Training the individual classifiers
The model starts with no individual classifiers and an
empty set of excluded features. In each step, the excluded
set of features is removed from the data, then a classi-
fier is fit to the data. Next the features used by the most
recent trained classifier are added to the excluded set. In
the case of a linear kernel SVM, this is achieved by find-
ing features with a non-zero coefficient in the model. This
way the features being used by classifiers are disjoint and
might represent different underlying causes of groups into
which samples are to be classified.
Combining classifiers by estimating confidences of individual
predictors
Given a set of classifiers, the question is how to combine
them to come up with a joint prediction value for each
test sample for which we want to predict the output label.
The intuition behind combining the classifiers is to put
more weight on classifiers that use features whose behav-
ior is similar to the training data. This is motivated by the
fact that some parts of the test data might behave very
differently to the training data, meaning that a classifier
using these features should have lower performance than
a classifier using features that are distributed similarly to
the training data. Therefore we need to evaluate the relia-
bility of the input features of each individual classifier. In
scenarios like gene expression or methylation analysis, we
usually have many input features. Furthermore, many fea-
tures are correlated and statistically dependent. The idea
of our new method is to build separate prediction models
for each feature of each classifier. These prediction mod-
els can then be used to obtain a confidence for the feature
in a given test sample. These confidences can then be
combined for each classifier to give a weighting of the clas-
sifiers for the given test sample. To evaluate an observed
feature f, we try to choose a few statistically dependent
features, and fit a model to predict f. To find these fea-
tures, first the estimated maximal information coefficient
(MIC) of all other features with feature f is calculated [26].
Then, features having MIC value within the top 5 % or
the 5 features with highest MIC with f (if the top 5 %
features consist of less than 5 features), are selected as pre-
dictors of f. Given a test sample, the closer the predicted
value of f is to the observed value, the more reliable it
is. To quantify this, we need to not only know the pre-
dicted value of the feature, but also a confidence interval
for that prediction. This can be achieved using Gaussian
processes, which give the mean and variance of the poste-
rior probability under the condition of observed values for
selected features. A weighted average of these values gives
us the overall reliability of the features of an individual
classifier.
In addition to the confidence in the classifier estimated
by looking at the confidences of its individual features, we
also account for the confidence that the classifier has in
the prediction label of the test sample. If the method sup-
plies such a confidence value (e.g., Gaussian processes),
we can directly use it. Otherwise, we estimate it using
the decision value. In our setting, the linear SVM gives
a decision value whose sign defines the predicted class.
Using these values we estimate a confidence for each
individual classifier. Several approaches exist for deriv-
ing a confidence from the decision values [27]. Whether
these or other additional methods could lead to further
improvements of our method, will be topic of further
study.
More formally speaking, define X to be the set of input
samples, Xs to be the input vector of sample s, ys and yˆs
to be respectively the original label and predicted output
of sample s,  to be the set of individual classifiers, li to
be an individual classifier, li the set of input features of
classifier li, li(Xs) to be the label predicted by classifier li
for sample Xs, and f to be a feature, Xs,f to be the observed
value of feature f in sample Xs, |wli( f )| to be the absolute
value of the weight of feature f in the decision function of
classifier li, and gf to be the Gaussian process predicting
feature f using feature set f . Also μgf (Xs) and σgf (Xs) are
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the mean and standard deviation of the posterior prob-
ability given by Gaussian process gf under the condition
of observing values of features in f , and μli and σli are
respectively the expected mean and standard deviation of
the decision value of classifier li. Here F is the cumulative
distribution function of a standard normal distribution.
The training phase of the model is shown in Fig. 1,
in which, N is the number of individual learners to be
included in the model, l is the union over all li and
X−l is the input X after discarding all features of the set
l. TOP is the function which selects the maximum of the
top 5 and top 5 % features f ′ of all features ordered byMIC
with feature f.
Now given a test sample Xs, the estimated confidence of
a feature f is:









Then the overall feature reliability or confidence of a
classifier li is estimated as:
c1li(Xs) :=
∑




Also the estimated output confidence of the classifier li
is:
c2li(Xs) := 1 − 2 · F
(
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and the final confidence of the classifier li is then:
cli(Xs) := c1li(Xs) · c2li(Xs) (4)
Finally, the predicted class yˆs is calculated as the sign of
a weighted vote among individual classifiers:
yˆs := sign
(∑




Visualization of model predictions
The interpretation of the model can be understood on two
different ways. First we assume for a given training data
set, the model is trained and a new test sample is given.
For the given test sample it is possible to visualize the reli-
ability of each used feature in individual classifiers, as well
as the overall confidence of each individual classifier. Used
features can be superimposed onto a PPI network as well
as their reliability and the confidence of their respective
individual classifier.
Gene expression and methylation level measurements
from cancer samples are usually very noisy. Furthermore,
cancers are usually very heterogeneous. Additionally,
there might be different subgroups for each interesting
group (e.g., cancer stage), for which the importance of the
features also differs. To get a global picture of the impor-
tant features, we therefore evaluate how often certain
Fig. 1 UML activity diagram of the training process
features are selected by the classifiers using 100 random
train test partitionings with 80 % of the data for training
and 20 % of the data for testing. To visualize high confi-
dence relationships between features, we create a graph
which has a node for every chosen feature in any of the
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100 train partitions in any of the individual classifiers.
The weight of an edge (s, t) is defined as the number of
times the respective features have occurred together in
an individual classifier. Then, all edges with low weights
are discarded. In order to find a threshold to prune edges
according to their weights, a Gaussian kernel density esti-
mate is fit to the weights of the edges, and the threshold is
chosen at the 90th percentile. Nodes that have an appear-
ance frequency higher than the threshold are labeled by
their gene names and edges having a higher weight than
the threshold are kept in the graph.
For illustration purposes, choosing the regularization
parameter is done in a way to maximize the number of
genes selected with high confidence, as well as minimiz-
ing the number of genes pruned out in the process. It
is important to remember that considering the results of
the method under different regularization parameters is
essential to make sure the selected genes possess a high
confidence and are also stable regardless of sampling of
the training data set.
Implementation details
To compare the performance of our method with other
methods, the implementations present in Python scikit-
learn(0.14) package are taken. In the case of stochastic
gradient boosting, the representing class is Gradient-
BoostingClassifier, the number of classifiers is set to 100,
and to make it sparse and prevent over-fitting, the maxi-
mum number of features for splits in trees is set to 5, and
the maximum number of layers is set to 2. For AdaBoost,
AdaBoostClassifier is used, which is an implementation
of AdaBoost-SAMME [28], with weak learner set to Deci-
sionTreeClassifier with maximum depth set to 2, and the
number of weak classifiers set to 100. Parameters of the
two boosting algorithms are chosen by a grid search on
their parameter space over all the data sets and selecting
the parameter sets which give a robust and stable result
over all experiments.
As an SVM, ν-SVM with ν = 0.25 is used, once with
a linear kernel, and once with an RBF kernel; γ parame-
ter of the RBF kernel is set to (num of features)−1. The ν
parameter is set to the maximum value for which the opti-
mization function is solvable with libsvm for all analyzed
data sets [29]. Smaller values cause the SVM to overfit to
the data and not generalize well. The Gaussian process’s
correlation function is a squared-exponential, and MIC is
estimated usingminepy package [30].
The PPI network used in our analysis is from the Human
Protein Reference Database (HPRD) [31]. Almost all edges
and relationships between proteins that are added to
this database are manually extracted from literature by
biologists, hence it has a lower rate of edges included




The performance of the method was compared with
that of two ensemble methods, AdaBoost and stochastic
gradient boosting, as well as an SVM with linear ker-
nel, and an SVM with an RBF kernel. We also included
our implementation of the NICK method [4]. We ran-
domly partitioned the data into training and test sets
with 80 % of the data for training and 20 % of the data
for testing. To compare the performance of the different
methods, Area Under the receiver operating character-
istic Curve (AUC) [32] was calculated on the test set
over the decision values returned by the methods on
the individual samples. The process was repeated 100
times to reduce random effects. As seen in Fig. 2, over-
all performances of all methods are comparable. In some
cases a single SVM works better, in some other cases
ensemble algorithms give a better performance. How-
ever, in most cases an improvement in performance is
observed by adding individual learners to the model, with
the greatest gains due to the first few individual learn-
ers added to the model. In two cases, TCGA-LAML/Vital
status and TCGA-LAML/Risk Group, our reported per-
formance measures are significantly lower than other
methods. This, however, comes from the fact that we have
enforced extreme sparsity measures. The performance
of the method increases and reaches the other meth-
ods’ performance levels if this constraint is relaxed, as
reported in Additional file 2. We enforced those sparsity
measures for all models to avoid over-fitting. Optimiz-
ing the sparsity constraint via cross-validation would have
been computationally expensive, which is why we pre-
ferred to be conservative. Had we optimized the sparsity
constraint, we would have still been able to find the sig-
nificant features while having similar performance as the
other methods. We would like to note that as shown
in Additional file 2, for TCGA-LAML/Vital status and
TCGA-LAML/Risk Group, the performance of a single
learner seems to be better than having multiple learners.
This could be due to the fact that the hidden underly-
ing data distribution is more homogeneous than in the
other prediction tasks (e.g., there is only one batch).
Furthermore, there is generally no free lunch in opti-
mization [33], meaning loosely speaking that there will
always be a data set where a novel method performs
worse than other methods. We plan to investigate these
cases further (i.e., can we estimate when it is better to
use one learner instead of multiple learners), and improve
our method to tackle the peculiarities of these data
sets.
Interpretability of predictions
Here we present the results of running the method on the
TCGA-LAML gene expression data set.











































































































































































































































































































































































































































































































































Fig. 2 Performance Summary (AUC). Each box shows a 25–75 % interval, as well as the median, which is shown as a horizontal line in each box
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Visualization of features important for a particular test
sample
Having a model trained on the data, and given a test sam-
ple, it is possible to infer and visualize which individual
classifier(s) is (are) influencing the prediction most. To
this end, individual learners as well as the features they
use are visualized as in Fig. 3a. In this figure, nodes with
labels starting with “L_” represent individual classifiers,
and other nodes are labeled with their respective gene
name. The color of the node shows its confidence com-
pared to other nodes; the darker the node, the higher the







































Fig. 3 Visualization of one model. A sample model for TCGA-LAML
gene expression data (a) individual classifiers and their selected
features; higher confidence of a node is shown by a darker color,
(b) selected genes plotted over the PPI network; green and yellow
show low and high confidence respectively, and the thickness of the
border of the node shows the respective confidence of the individual
classifier to which it belongs
reliability of the feature (cf ), and in the case of an indi-
vidual classifier, it is the overall estimated confidence (cli ).
Edges show which classifier is using which genes in its
decision function. The shape of a node represents the
individual classifier they belong to.
To get a better overview of the individual features
that were chosen by the classifiers for the particular
test sample, we visualized the corresponding genes on a
graph containing information about the PPI network in
Fig. 3b. We extracted the PPI information from HPRD
as explained before. This way, it is possible to find over-
or under-regulated pathways that might be responsible
for the label (e.g., cancer stage) of the test sample. Since
PPI networks can be quite dense, we removed parts of
the induced network. For this purpose we computed each
shortest path between all pairs of selected features. Then,
the minimum spanning tree of that section was plotted,
after removing branches with no selected feature.
Most of the features chosen by any of the classifiers
(colored nodes) are not connected to any other chosen
feature. It is known that there is in many cases a correla-
tion between expression value of the genes whose corre-
sponding proteins interact [34]. Therefore, a regularized
model will only choose a subset of the correlated features.
This explains the observation that features selected by a
single model can be distant from each other on a PPI net-
work; but if multiple disjoint sparse models are fit to the
data, their selected features might happen to be close to
each other on the PPI network (e.g., node TPT1 and node
EEF1A1 in Fig. 3b).
Visualization of important global features
As explained in Section “Visualization of model predic-
tions”, a graph is created from model structures of all 100
random training partitions, and then it is pruned to keep
only high confidence nodes and edges. The density esti-
mation of the graph edge weights and the pruned graph
are plotted in Fig. 4a, b where the nodes with labels are the
ones that are not pruned. The nodes in this figure that do
not have any label, are the ones with frequency lower than
the corresponding threshold. Among the features consid-
ered to be important were features that had previously
been linked to leukemia such as SH3KBP1 [35].
What was more intriguing to see was that four out of
the seven important features of the TCGA-LAML gene
expression data set contained ribosomal proteins when
using the risk group label, i.e. RPL37A, RPS20, RPS3A,
and RPL23A. For a long time ribosomes were just con-
sidered machines that perform an unbiased translation of
genes from mRNA to amino acid sequences, but this view
has recently been challenged [36]. One new hypothesis
is that the ribosome introduces an additional regulatory
layer. Therefore, it could very well be that mutations
in ribosomal proteins can lead to a misregulation of


















Fig. 4 a Determine pruning threshold. Threshold is determined by
finding the point after which, 90 % of the area under the curve is
observed from left to right. The horizontal axis shows the observed
frequency or weight of the edges. b Important Global Features High
confidence nodes and edges of the graph generated from the model
on TCGA-LAML gene expression data. Darker color represents higher
rate of being selected by a classifier
expression levels of important genes and ultimately to the
development of cancer (in this case leukemia). One of the
ribosomal proteins we found was RPL23A. It has been
shown that loss of RPL23A can impede growth and lead
to morphological abnormalities in Arabidopsis Thaliana
[36]. Therefore, a mutation in RPL23A might also have
severe effects in humans. Amissense mutation in RPL23A
was recently found in patients having Diamond-Blackfan
anemia, which is an inherited form of pure red cell aplasia
(related to leukemia) [37]. Note that the model for LAML
has low performance for the regularization value chosen.
Nevertheless, the features shown here are also the ones
with the highest confidence for models learnt with less
regularization (with several other additional features). The
models with less regularization show similar performance
to the other methods shown in Fig. 2.
Conclusions
Machine learning has become more and more popular in
many real world scenarios formaking sense of large collec-
tions of facts. Differences between the data used for train-
ing the method and new data for which the label should be
predicted can limit the performance of prediction meth-
ods on those data. In this work we introduced a method
that estimates these potential partial biases and incorpo-
rates them into the prediction function. We applied it
to gene expression and DNA methylation measurements
from cancer patients. Our method has state-of-the-art
performance on many different prediction tasks. Further-
more, we show how to make sense of the predictions.
Visualizing the important genes can lead to new biological
insights, as shown for the TCGA-LAML data set with the
risk group label. Instead of mapping the genes to PPI net-
works, one could also think of mapping them to signaling
pathways [38].
Recently, a study showed that most published signa-
tures are not significantly more associated with cancer
outcome than random signatures [39]. One of the rea-
sons for this finding is that the data comes from slightly
different underlying hidden data distributions. Since our
new method estimates this bias and corrects for it by up-
weighting the classifiers that have higher confidence, we
expect that it should be less susceptible to such differences
in the data.
In this work we designed and developed a method
that besides being a predictive model, it can be used for
two different purposes. It can be used as an exploratory
method to reveal potential features used in future studies;
and it can be used to different underlying causes of the
same disease and with its interpretability help oncologists
to choose the treatment accordingly.
We would like to point out that the applicability of our
method is not limited to cancer outcome prediction, and
it can apply to manymore scenarios. Themethod assumes
that the data has enough features to select from, and that
there are related features to those selected ones that can
be used to estimate their reliability. These are conditions
that almost all biological data satisfy, hence the method
can be applied to them.
Themethod also works as a skeleton whose components
can be easily substituted. For example, by changing the
classifier used in individual learners to a multi-class clas-
sifier, the method would work on multi-class problems.
For the sake of simplicity and without loss of generality
we performed the evaluations only on binary classification
problems. Also, due to the structure of our model, one
possible approach would be to use a method such as iRDA
and use those gene sets as features of individual learn-
ers. Whether this approach leads to better results or not
requires further research. Also, the combination of maxi-
mal information coefficient and Gaussian processes is not
Jalali and Pfeifer BMCGenomics  (2016) 17:501 Page 10 of 10
the only feasible option, and they can be replaced with
other faster methods if the time complexity of the method
is of any concern. Some of these alternatives are already
available on the github repository of the method.
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